Related Experiment Video
Updated: May 19, 2026

04:38
A Murine Tail Lymphedema Model
Published on: February 10, 2021
Development of a framework for pneumatic device selection for lymphedema treatment
Sonja M Maul1, Julie A Devine, Carolyn R Wincer
1St. Luke's Idaho Elks Rehabilitative Services, Boise, ID, USA.
Medical Devices (Auckland, N.Z.)
|August 24, 2012
Summary
Programmable pneumatic compression devices (PCDs) effectively managed difficult leg and trunk lymphedema cases. Lower pressure PCDs with smaller chambers improved patient outcomes and self-care for home discharge.
Area of Science:
- Medical Science
- Rehabilitation Medicine
- Vascular Health
Background:
- Lymphedema, particularly leg and trunk presentations, presents management challenges.
- Combined decongestive therapy is the standard of care but can be difficult for some patients to self-manage.
- Achieving independent self-care is crucial for patient discharge, but often impeded in complex lymphedema cases.
Observation:
- Three patients with challenging leg and trunk lymphedema were treated with standard care and programmable pneumatic compression devices (PCDs).
- Obstacles to independent self-care and home discharge were noted.
- Two different PCDs were evaluated for their efficacy in enabling patients to meet discharge goals.
Findings:
- Programmable PCDs demonstrated effectiveness in managing complicated lymphedema.
- Differences between PCDs were observed; lower pressures and smaller chambers yielded better patient tolerance and outcomes.
- In-home use of appropriate PCDs facilitated stable limb volumes and symptom control in advanced lymphedema stages.
Implications:
- Programmable PCDs can be a valuable tool for managing advanced and difficult-to-treat lymphedema in a home setting.
- Patient selection and device choice are critical for successful home-based PCD therapy.
- This approach supports patient independence and successful transition to home care for lymphedema management.

